Vivos Therapeutics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Vivos Therapeutics, Inc. (VVOS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $50.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-14
- Vivos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $50.00K, a 79.34% decline year-over-year.
- Vivos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $151.00K, a 52.37% decline year-over-year.
- Vivos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $55.00K, a 61.27% decline year-over-year.
- Vivos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $242.00K, a 10.37% decline year-over-year.
- Vivos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $661.00K, a 13.25% decline from fiscal 2024.
- Vivos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $762.00K, a 31.10% decline from fiscal 2023.
- Vivos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.11M, a 53.84% decline from fiscal 2022.
- Vivos Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $2.40M, a 9.86% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50.00K 10-Q · filed 2026-08-14 | $201.00K derived: sum of 2 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $151.00K 10-Q · filed 2026-08-14 | |||||
| 2025-12-31 | $661.00K 10-K · filed 2026-04-15 | |||||
| 2025-09-30 | $55.00K 10-Q · filed 2025-11-19 | $297.00K derived: sum of 2 quarters · filed 2026-08-14 | $614.00K derived: sum of 3 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $242.00K 10-Q · filed 2026-08-14 | $559.00K derived: sum of 2 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $317.00K 10-Q · filed 2026-08-14 | |||||
| 2024-12-31 | $762.00K 10-K · filed 2026-04-15 | |||||
| 2024-09-30 | $142.00K 10-Q · filed 2025-11-19 | $412.00K derived: sum of 2 quarters · filed 2025-11-19 | $705.00K derived: sum of 3 quarters · filed 2025-11-19 | |||
| 2024-06-30 | $270.00K 10-Q · filed 2025-11-19 | $563.00K derived: sum of 2 quarters · filed 2025-11-19 | ||||
| 2024-03-31 | $293.00K 10-Q · filed 2025-11-19 | |||||
| 2023-12-31 | $1.11M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $189.00K 10-Q · filed 2024-11-14 | $648.00K derived: sum of 2 quarters · filed 2024-11-14 | $954.00K derived: sum of 3 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $459.00K 10-Q · filed 2024-11-14 | $765.00K derived: sum of 2 quarters · filed 2024-11-14 | ||||
| 2023-03-31 | $306.00K 10-Q · filed 2024-11-14 | |||||
| 2022-12-31 | $2.40M 10-K/A · filed 2024-07-30 | |||||
| 2022-09-30 | $350.00K 10-Q · filed 2023-11-14 | $1.01M derived: sum of 2 quarters · filed 2023-11-14 | $1.62M derived: sum of 3 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $661.00K 10-Q · filed 2023-11-14 | $1.27M derived: sum of 2 quarters · filed 2023-11-14 | ||||
| 2022-03-31 | $609.00K 10-Q · filed 2023-11-14 | |||||
| 2021-12-31 | $2.66M 10-K · filed 2023-03-30 | |||||
| 2021-09-30 | $1.11M 10-Q · filed 2022-12-20 | $1.11M 10-Q · filed 2021-11-15 | $1.76M derived: sum of 2 quarters · filed 2022-12-20 | $2.19M derived: sum of 3 quarters · filed 2022-12-20 | ||
| 2021-06-30 | $648.00K 10-Q · filed 2022-12-20 | $648.05K 10-Q · filed 2021-08-12 | $1.08M derived: sum of 2 quarters · filed 2022-12-20 | |||
| 2021-03-31 | $434.00K 10-Q · filed 2022-12-20 | $434.29K 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $2.17M 10-K · filed 2022-03-31 | $2.17M 10-K · filed 2021-03-25 | ||||
| 2020-09-30 | $428.66K 10-Q · filed 2021-11-15 | $994.03K derived: sum of 2 quarters · filed 2021-11-15 | $1.35M derived: sum of 3 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $565.37K 10-Q · filed 2021-11-15 | $917.27K derived: sum of 2 quarters · filed 2021-11-15 | ||||
| 2020-03-31 | $351.89K 10-Q · filed 2021-11-15 | |||||
| 2019-12-31 | $1.99M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |